Company: PFSA
Filing Date: 2025-05-09
Form Type: S-4/A
Source: 0001213900-25-041151
Chunk: 371

Company: Profusa, Inc.
Filing Date: 2025-05-09
Form: S-4/A
Chunk 371
---
   |     |             |       |   |
| Weighted average shares outstanding of Profusa common stock – basic and diluted            |     |               | 5,600,741 |   |     |              |           |   |     |                    |            |   |     |             |            |   |     |                    |       |   |     |             |       |   |
| Net loss per share of New Profusa common stock – basic and diluted                         |     |               |           |   |     |              |           |   |     | $                  |      (0.40 | ) |     | $           |      (0.52 | ) |     | $                  | (0.12 | ) |     | $           | (0.15 | ) |
| Weighted average shares outstanding of New Profusa common stock – basic and diluted(4)     |     |               |           |   |     |              |           |   |     |                    | 33,002,012 |   |     |             | 32,949,853 |   |     |                    |       |   |     |             |       |   |

____________ (1)There were no cash dividends declared in the period presented. (2)Book value per share is calculated as (a) total permanent equity divided by (b) the total number of shares of New Profusa Common Stock outstanding classified in permanent equity.

197

(3)The equivalent per share data for Profusa is calculated by multiplying the combined pro forma per share data by the Exchange Ratio, as determined in accordance with the Merger Agreement. (4)The pro forma weighted average common shares outstanding include (a) outstanding convertible preferred stock of Profusa, which is entitled to the same per share merger consideration as Profusa common stock on an as converted to common stock basis, and (b) common stock of New Profusa issuable upon the conversion of junior convertible notes and senior convertible notes of Profusa. The following potential shares were excluded from the calculation of diluted net loss per share:

|                                                    |     |        As of 
 December 31, 
         2024 |     |        As of 
 December 31, 
         2023 |
|:---------------------------------------------------|:----|-------------:|:----|-------------:|
| Shares underlying NorthView’s outstanding warrants |     |   17,404,250 |     |   17,404,250 |
| Milestone Earnout Shares